Biotech

Krystal Biotech is experiencing a significant rise in short interest, with 14.58% of its shares sold short. This increase signifies a shift in investor sentiment, implying expectations of a short-term…

Edesa Biotech focuses on innovation in biotech, particularly in developing the inflammatory treatment paridiprubart. Research and development saw a significant investment increase, exceeding $300,000, highlighting their commitment to healthcare advancements.…